Home > Insider Trading > Filing (0001140361-13-019271)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1048477	Biomarin Pharmaceutical Inc	BMRN	Pharmaceutical Preparations (2834)	680397820

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1274826	Robert Baffi	C/O Biomarin Pharmaceutical Inc. 105 Digital Drive Novato CA 94949	Evp, Technical Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-04-30	805	$23.21	53,155	No	5	A	Direct
Common Stock	Acquisiton	2013-05-03	20,000	$14.39	73,155	No	4	M	Direct
Common Stock	Disposition	2013-05-03	20,000	$67.00	53,155	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	5	A	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy) Common Stock	Disposition	2013-05-03	20,000	$0.00	20,000	$14.39

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,051	2009-11-12	2019-05-11	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	8,238	Indirect	Shares held by Baffi Family Trust

Footnotes

The reporting peson is voluntarily reporting the aquisition of shares of theissuer's common stock pursuant to the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP Purchase period of November 1, 2012 to April 30, 2013.
Transaction made pursuant to a Rule 10b5-1 plan executed on March 4, 2013.
All shares sold at the same price.
Options vest 6/48ths on November 12, 2009 and 1/48th on the 12th of each month thereafter.
Reflects the number of stock options that remain outstanding from this specific stock option grant following the reported transaction.